{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:59:05Z","timestamp":1791475145414,"version":"4.3.4"},"reference-count":60,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,10]]},"DOI":"10.18632\/oncotarget.5462","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T01:26:06Z","timestamp":1445217966000},"page":"37471-37485","source":"Crossref","is-referenced-by-count":42,"title":["Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth<i>in vivo<\/i>"],"prefix":"10.18632","volume":"6","author":[{"given":"Annarita","family":"Miluzio","sequence":"first","affiliation":[{"name":"Molecular Histology and Cell Growth Unit, Istituto Nazionale Genetica Molecolare, \u201cRomeo ed Enrica Invernizzi\u201d, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Oliveto","sequence":"additional","affiliation":[{"name":"Molecular Histology and Cell Growth Unit, Istituto Nazionale Genetica Molecolare, \u201cRomeo ed Enrica Invernizzi\u201d, Milano, Italy"},{"name":"Dipartimento di Scienze e Innovazione Tecnologica, University of Eastern Piedmont, Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pesce","sequence":"additional","affiliation":[{"name":"Molecular Histology and Cell Growth Unit, Istituto Nazionale Genetica Molecolare, \u201cRomeo ed Enrica Invernizzi\u201d, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Mutti","sequence":"additional","affiliation":[{"name":"Biomedicine Institute, The University of Salford, The Crescent, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Murer","sequence":"additional","affiliation":[{"name":"Hospital Dall'Angelo, Pathology Unit, Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Grosso","sequence":"additional","affiliation":[{"name":"Medical Research Council Toxicology Unit, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ricciardi","sequence":"additional","affiliation":[{"name":"Molecular Histology and Cell Growth Unit, Istituto Nazionale Genetica Molecolare, \u201cRomeo ed Enrica Invernizzi\u201d, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Brina","sequence":"additional","affiliation":[{"name":"Molecular Histology and Cell Growth Unit, Istituto Nazionale Genetica Molecolare, \u201cRomeo ed Enrica Invernizzi\u201d, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Biffo","sequence":"additional","affiliation":[{"name":"Molecular Histology and Cell Growth Unit, Istituto Nazionale Genetica Molecolare, \u201cRomeo ed Enrica Invernizzi\u201d, Milano, Italy"},{"name":"Department of Biosciences, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/onc.2013.153","article-title":"Translation factors and ribosomal proteins control tumor onset and progression: how?","volume":"33","author":"Biffo","year":"2014","journal-title":"Oncogene"},{"key":"2","first-page":"254","article-title":"Translational control in cancer","volume":"10","author":"Schneider","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Topisirovic","year":"2015","journal-title":"Nature reviews Drug discovery"},{"key":"4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012336","article-title":"Translational control in cancer etiology","volume":"5","author":"Ruggero","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia","volume":"45","author":"Vandepoel","year":"2013","journal-title":"Nature genetics"},{"key":"6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets","volume":"136","author":"Hinnebusch","year":"2009","journal-title":"Cell"},{"key":"7","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","article-title":"mTOR, translation initiation and cancer","volume":"25","author":"Sonenberg","year":"2006","journal-title":"Oncogene"},{"key":"8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Sonenberg","year":"2010","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Ruggero","year":"2010","journal-title":"Cancer Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Pandolfi","year":"2004","journal-title":"Nat Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1101\/gad.1604407","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Lowe","year":"2007","journal-title":"Genes Dev"},{"key":"12","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-12-2395","article-title":"eIF4E\/4E-BP ratio predicts the efficacy of mTOR targeted therapies","volume":"72","author":"Sonenberg","year":"2012","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"13907","DOI":"10.1074\/jbc.M110782200","article-title":"4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin","volume":"277","author":"Houghton","year":"2002","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"crossref","first-page":"e27245","DOI":"10.4161\/trla.27245","article-title":"Cap dependent translation contributes to resistance of myeloma cells to bortezomib","volume":"1","author":"Biffo","year":"2013","journal-title":"Translation"},{"key":"15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Blenis","year":"2014","journal-title":"Cell Metab"},{"key":"16","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Blenis","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI37539","article-title":"Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus","volume":"120","author":"Gallicchio","year":"2010","journal-title":"J Clin Invest"},{"key":"18","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1016\/S0021-9258(18)34440-5","article-title":"Eukaryotic ribosomal subunit anti-association activity of calf liver is contained in a single polypeptide chain protein of Mr = 25,500 (eukaryotic initiation factor 6)","volume":"257","author":"Maitra","year":"1982","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1083\/jcb.144.5.823","article-title":"The beta4 integrin interactor p27(BBP\/eIF6) is an essential nuclear matrix protein involved in 60S ribosomal subunit assembly","volume":"144","author":"Biffo","year":"1999","journal-title":"J Cell Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nature07267","article-title":"Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation","volume":"455","author":"Biffo","year":"2008","journal-title":"Nature"},{"key":"21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ccr.2011.04.018","article-title":"Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth","volume":"19","author":"Biffo","year":"2011","journal-title":"Cancer Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.0805139105","article-title":"A quantitative atlas of mitotic phosphorylation","volume":"105","author":"Gygi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nature02160","article-title":"Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly","volume":"426","author":"Biffo","year":"2003","journal-title":"Nature"},{"key":"24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1104\/pp.110.160663","article-title":"Involvement of Arabidopsis RACK1 in protein translation and its regulation by abscisic acid","volume":"155","author":"Chen","year":"2011","journal-title":"Plant Physiol"},{"key":"25","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1172\/JCI58488","article-title":"Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma","volume":"122","author":"Gu","year":"2012","journal-title":"J Clin Invest"},{"key":"26","first-page":"510","article-title":"Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer","volume":"60","author":"Marchisio","year":"2000","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ng.3073","article-title":"An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer","volume":"46","author":"Perou","year":"2014","journal-title":"Nat Genet"},{"key":"28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Yang","year":"2012","journal-title":"Journal of cellular physiology"},{"key":"29","doi-asserted-by":"crossref","first-page":"e29136","DOI":"10.1371\/journal.pone.0029136","article-title":"Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1","volume":"6","author":"Biffo","year":"2011","journal-title":"PLoS One"},{"key":"30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/JTO.0000000000000360","article-title":"SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)","volume":"10","author":"Gandara","year":"2015","journal-title":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","article-title":"Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling","volume":"166","author":"Bueno","year":"2005","journal-title":"Am J Pathol"},{"key":"32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/BJ20080463","article-title":"PKCbetaII modulates translation independently from mTOR and through RACK1","volume":"415","author":"Biffo","year":"2008","journal-title":"Biochem J"},{"key":"33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjh.12853","article-title":"Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma","volume":"166","author":"Dreyling","year":"2014","journal-title":"Br J Haematol"},{"key":"34","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/1535-7163.MCT-10-0413","article-title":"Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis","volume":"9","author":"Graff","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"35","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/0008-5472.CAN-05-0071","article-title":"The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts","volume":"65","author":"Brown","year":"2005","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/onc.2013.153","article-title":"Translation factors and ribosomal proteins control tumor onset and progression: how?","volume":"33","author":"Biffo","year":"2014","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1038\/ncomms9261","article-title":"eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription","volume":"6","author":"Hrabe de Angelis","year":"2015","journal-title":"Nature Communications"},{"key":"38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-014-0301-3","article-title":"Evaluation of clonal origin of malignant mesothelioma","volume":"12","author":"Pass","year":"2014","journal-title":"Journal of translational medicine"},{"key":"39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"40","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00018-014-1584-5","article-title":"Role of microRNAs in malignant mesothelioma","volume":"71","author":"Grossi","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728210903074563","article-title":"Malignant pleural mesothelioma: current treatments and emerging drugs","volume":"14","author":"Mutti","year":"2009","journal-title":"Expert opinion on emerging drugs"},{"key":"42","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/onc.2009.423","article-title":"p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis","volume":"29","author":"Lozano","year":"2010","journal-title":"Oncogene"},{"key":"43","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.4161\/cc.10.20.17796","article-title":"Translational control by 80S formation and 60S availability: The central role of eIF6, a rate limiting factor in cell cycle progression and tumorigenesis","volume":"10","author":"Biffo","year":"2011","journal-title":"Cell Cycle"},{"key":"44","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4161\/psb.6.5.15438","article-title":"Eukaryotic initiation factor 6, an evolutionarily conserved regulator of ribosome biogenesis and protein translation","volume":"6","author":"Chen","year":"2011","journal-title":"Plant Signal Behav"},{"key":"45","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/CCO.0b013e3282f10a00","article-title":"Enzastaurin","volume":"19","author":"Rosen","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/CAD.0b013e32830ce506","article-title":"Protein kinase C beta in malignant pleural mesothelioma","volume":"19","author":"Salgia","year":"2008","journal-title":"Anticancer Drugs"},{"key":"47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/leu.2014.255","article-title":"Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma","volume":"29","author":"Chang","year":"2015","journal-title":"Leukemia"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2179","article-title":"The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines","author":"Sacchi","year":"2014","journal-title":"Hematological oncology"},{"key":"49","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/13543784.2013.812071","article-title":"Anti-angiogenic drugs currently in Phase II clinical trials for gynecological cancer treatment","volume":"22","author":"Wei","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"50","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3109\/10428194.2011.572265","article-title":"Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma","volume":"52","author":"Rosen","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"51","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s10495-011-0617-x","article-title":"HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells","volume":"16","author":"Hsi","year":"2011","journal-title":"Apoptosis : an international journal on programmed cell death"},{"key":"52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng1994","article-title":"The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast","volume":"39","author":"Warren","year":"2007","journal-title":"Nat Genet"},{"key":"53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2006.11.046","article-title":"Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G","volume":"128","author":"Wagner","year":"2007","journal-title":"Cell"},{"key":"54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Lupu","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"56","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nprot.2012.086","article-title":"The ribosome profiling strategy for monitoring translationby deep sequencing of ribosome-protected mRNA fragments","volume":"7","author":"Weissman","year":"2012","journal-title":"Nat Protoc"},{"key":"57","doi-asserted-by":"crossref","first-page":"e58051","DOI":"10.1371\/journal.pone.0058051","article-title":"Preclinical demonstration of synergistic Active Nutrients\/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma","volume":"8","author":"Burlando","year":"2013","journal-title":"PLoS One"},{"key":"58","doi-asserted-by":"crossref","first-page":"30314","DOI":"10.1074\/jbc.272.48.30314","article-title":"Isolation of a novel beta4 integrin-binding protein (p27(BBP)) highly expressed in epithelial cells","volume":"272","author":"Marchisio","year":"1997","journal-title":"J Biol Chem"},{"key":"59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Manning","year":"2010","journal-title":"Mol Cell"},{"key":"60","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1073\/pnas.0510452103","article-title":"Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency","volume":"103","author":"de Cabo","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T15:26:29Z","timestamp":1653319589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":60,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2015,11,10]]}},"alternative-id":["5462","26462016"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5462","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}